Selenomethionine Se 75

   
Google
 
Web NewDrugInformation.com

Selenomethionine Se 75


Drug - Selenomethionine Se 75
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Selenomethionine, Se-75
Multiple ingredients are in alphabetical order.

Strength - 100uCi/ML
The potency of the active ingredient(s), Selenomethionine, Se-75. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Selenomethionine Se 75. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017098
The FDA assigned number to Selenomethionine Se 75. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Selenomethionine Se 75. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Selenomethionine Se 75 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Selenomethionine Se 75. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Selenomethionine Se 75 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Inc
The full name of the firm holding legal responsibility for the new application of Selenomethionine Se 75.

Selenomethionine Se 75